5-Hydroxyindirubin targets FLT3 signaling and synergizes with venetoclax in FLT3-ITD acute myeloid leukemia

Authors:
  • YDYanshun Deng
    Yanshun Deng
  • CXChenghua Xu
    Chenghua Xu
  • BCBingqian Chu
    Bingqian Chu
  • JFJinting Fan
    Jinting Fan
  • NWNing Wang
    Ning Wang
  • YYYang Yang
    Yang Yang
  • PYPeiyuan Yang
    Peiyuan Yang
  • YFYouyang Fang
    Youyang Fang
  • LKLichun Kang
    Lichun Kang
  • MNMingming Niu
    Mingming Niu
  • XHXiaoxiao Huang
    Xiaoxiao Huang
  • GYGuodong Yao
    Guodong Yao

Abstract
No abstract available
Funding Information
  • Natural Science Foundation of Tianjin Municipality (22JCJQJC00090)
  • Sichuan Provincial Science and Technology Support Program (2023-QNRC2-B24)
  • Sichuan Provincial Science and Technology Support Program (2025ZNSFSC0737)
  • National Natural Science Foundation of China (82400271)
  • National Natural Science Foundation of China (82403710)
  • National Natural Science Foundation of China (82270236)
  • National Natural Science Foundation of China (82341080)
  • National Natural Science Foundation of China (82273217)
  • Chinese Academy of Medical Sciences (2025-I2M-XHXX-134)
  • Chinese Academy of Medical Sciences (2025-I2M-XHJC-037)
  • Chinese Academy of Medical Sciences (2023-I2M-3-014)
  • Chinese Academy of Medical Sciences (2023-I2M-2-007)
  • Chinese Academy of Medical Sciences (2025-I2M-XHXX-135)

This publication has 27 references indexed in Scilit: